Ceftazidime (Fortum) is a third-generation cephalosporin with anti-pseudomonal activity. It is used to treat the following infections:
- Treatment of Bacterial septicemia caused by:
- Pseudomonas aeruginosa,
- Klebsiella spp.,
- Haemophilus influenzae,
- Escherichia coli,
- Serratia spp.,
- Streptococcus pneumoniae, and
- methicillin-susceptible Staphylococcus aureus.
- Bone and joint infections caused by:
- Pseudomonas aeruginosa,
- Klebsiella spp.,
- Enterobacter spp., and
- Methicillin-susceptible Staphylococcus aureus.
- Treatment of meningitis and other CNS infections caused by:
- Haemophilus influenzae
- Neisseria meningitidis
- Pseudomonas aeruginosa and
- Streptococcus pneumoniae.
- Treatment of female genital infections, pelvic cellulitis, and endometritis caused by:
- Escherichia coli.
- Treatment of peritonitis and other Intra-abdominal infections caused by:
- Escherichia coli,
- Klebsiella spp., and
- methicillin-susceptible Staphylococcus aureus.
- Polymicrobial intra-abdominal infections ( caused by aerobic and anaerobic organisms and some Bacteroides spp.)
- Treatment of Pneumonia and other Lower respiratory tract infections caused by:
- Pseudomonas aeruginosa and other Pseudomonas spp.
- Haemophilus influenzae
- Enterobacter spp.
- Proteus mirabilis
- Escherichia coli
- Serratia spp.
- Citrobacter spp.
- Streptococcus pneumoniae
- methicillin-susceptible Staphylococcus aureus.
- Treatment of Skin and soft tissue infections caused by:
- Pseudomonas aeruginosa
- Klebsiella spp.
- Escherichia coli
- Proteus spp. (including Proteus mirabilis and indole-positive Proteus)
- Enterobacter spp.
- Serratia spp.
- methicillin-susceptible Staphylococcus aureus.
- Streptococcus pyogenes (group A beta-hemolytic streptococci).
- Complicated and uncomplicated Urinary tract infections (UTI) caused by:
- Pseudomonas aeruginosa
- Enterobacter spp.
- Proteus spp. (including Proteus mirabilis and indole positive Proteus)
- Klebsiella spp.
- Escherichia coli.
- Other Off-Label Uses of Ceftazidime in Adults include:
- Bacterial endophthalmitis
- Melioidosis ( caused by Burkholderia pseudomallei) infection
- As aerosolized treatment of Non–cystic fibrosis bronchiectasis.
Ceftazidime Dose in Adults
Ceftazidime dose in patients with Cystic fibrosis:
- Dose as recommended by the Manufacturer:
- 90 to 150 mg/kg/day intravenous thrice daily to a maximum of 6 gms daily
- Alternative recommendations:
- 200 to 400 mg/kg/day as an intermittent injection three or four times a day to a maximum dose of 8 - 12 g daily or
- by continuous intravenous infusion in a dose of 100 to 200 mg/kg/day to a maximum dose of 12 g daily
Empiric treatment of immunocompromised patients:
- 2 gms IV thrice daily
For the treatment of bacterial Endophthalmitis (off-label use):
- 2 to 2.25 mg/0.1 mL NS in combination with vancomycin as an intravitreal injection.
Ceftazidime Use in treatment of severe Intra-abdominal infection in combination with metronidazole:
- 2 gms IV thrice daily for 4 - 7 days
- It is not recommended for mild to moderate community acquired infections and hospital-acquired intraabdominal infections caused by multidrug-resistant gram-negative organisms
Off label use in the treatment of severe & acute phase of Melioidosis:
- 50 mg/kg/dose thrice daily to a maximum dose of 2 g or
- 2 gms for one dose, followed by 6 g daily by continuous intravenous infusion for 10 days or more with or without TMP/SMX
- Patients should be switched to meropenem if the condition worsens, new foci of infections develop, and a repeat blood culture is positive
Use in treatment of bacterial Meningitis:
- For empiric or pathogen-specific therapy:
- 2 gms IV thrice daily in combination with vancomycin
As inhalational therapy in Non-cystic fibrosis bronchiectasis:
- 250 to 1,000 mg twice daily or
- 500 mg four times a day for up to one year
Off label dose as an alternative therapy in native vertebral Osteomyelitis caused by P. aeruginosa:
- 2 gms intravenous thrice daily for 6 weeks.
- Dual therapy i.e. the addition of an aminoglycoside or ciprofloxacin may be considered.
Off label use as intraperitoneal administration in Peritonitis:
- Intermittent:
- 1 to 1.5 gm once a day per exchange in the long dwell (6 hours or more)
- Continuous (per liter exchange):
- Loading dose of500 mg, followed by
- Maintenance dose of 125 mg.
Dose in the treatment of uncomplicated, hospital-acquired, and ventilator-associated Pneumonia:
- Uncomplicated pneumonia:
- 500 mg to 1 g IM or IV thrice daily
- Hospital-acquired or ventilator-associated as an off-label treatment:
- 2 gms thrice daily for 7 days
- The duration of therapy may be increased or reduced based on clinical response.
As an alternative to cefepime or meropenem in the treatment of prosthetic joint infections caused by Pseudomonas aeruginosa:
- 2 gms thrice daily for 4 to 6 weeks
- The addition of aminoglycosides may be considered
Use in treatment of Skin and soft tissue infections:
- 500 mg to 1 g IM or IV thrice daily
Use in treatment of Severe infections including osteomyelitis and gynecological infections
- 2 gms intravenous thrice daily
Use in the treatment of Urinary tract infections:
- As per the Manufacturer’s recommendations:
- Uncomplicated UTI:
- 250 mg IM or IV twice daily
- Complicated UTI:
- 500 mg IM or IV twice or thrice daily
- Uncomplicated UTI:
- Alternative recommendations:
- Complicated UTI:
- 1 to 2 g intravenous twice or thrice daily.
- Complicated UTI:
Ceftazidime Dose in Childrens
Ceftazidime general dosing in susceptible infection:
- Infants, Children, and Adolescents:
- Mild to moderate infections:
- 90 to 150 mg/kg/day in three divided doses to a maximum dose of 3 gms per day
- Severe infections:
- 200 mg/kg/day in three divided doses to a maximum daily dose of 6 gms/day.
- Patients with cystic fibrosis may require higher doses up to 300 mg/kg/day
- Mild to moderate infections:
Ceftazidime in lung infection caused by Pseudomonas spp in patients with Cystic fibrosis:
- Infants, Children, and Adolescents:
- 150 to 200 mg/kg/day intravenous in three or four divided doses to a maximum daily dose of 6 gms per day.
- Some experts have used higher doses in the range of 200 to 400 mg/kg/day in three or four divided doses to a maximum dose of 12 g/day
Use of Ceftazidime for the treatment of Endocarditis:
- Children and Adolescents:
- 100 to 150 mg/kg/day intravenous in three divided doses to a maximum dose of 4000 mg//day (in combination with gentamicin or vancomycin and gentamicin depending on the cause)
Use of Ceftazidime for treatment of complicated Intra-abdominal infections:
- Infants, Children, and Adolescents:
- 50 mg/kg/dose intravenous thrice daily in combination with metronidazole to a maximum daily dose of 6 g/day.
Use of Ceftazidime for treatment of Meningitis:
- Infants, Children, and Adolescents:
- 150 mg/kg/day in three divided doses to a maximum dose of 6 g/day.
Use of Ceftazidime in treatment of Peritonitis in patients on peritoneal dialysis:
- Infants, Children, and Adolescents:
- Intermittent peritoneal dialysis: 20 mg/kg/dose intraperitonally once a day in the long dwell
- Continuous peritoneal dialysis:
-
- A Loading dose of 500 mg per liter of dialysate
- a maintenance dose of 125 mg per liter
-
Use of Ceftazidime for treatment of Urinary tract infection:
- Infants and Children 2 - 24 months:
- 100 to 150 mg/kg/day intravenous in three divided doses.
Pregnancy Risk Factor B
- Ceftazidime(Fortum).Crosses the placental boundary, but there have been no adverse drug reactions when taken during pregnancy.
- It can be used to treat susceptible infections in pregnant women.
Ceftazidime(Fortum).use during breastfeeding:
- Ceftazidime can be added to breastmilk. However, it is compatible with breastfeeding.
- Because it can be taken orally, there are no systemic risks.
Ceftazidime Dose in Renal Disease:
- Ceftazidime dosage in Renal disease:
- CrCl 31 - 50 mL/minute: 1 gm twice daily
- CrCl 16 - 30 mL/minute: 1 gm once a day
- CrCl 6 - 15 mL/minute: 500 mg once a day
- CrCl less than 5 mL/minute: 500 mg every other day
- Intermittent hemodialysis (50% to 100% dialyzable - administer the dose after hemodialysis):
- 500 mg - 1 g once a day or
- 1 - 2 g every second or third day.
- Intermittent Peritoneal dialysis:
-
-
- Loading dose of 1 gm IV, followed by 500 mg once a day
-
-
- Continuous peritoneal dialysis:
-
-
- Loading dose of 1 gm IV, followed by 500 mg once a day.
-
-
- CVVH:
- A Loading dose of 2 gms followed by 1 - 2 g twice daily
- CVVHD/CVVHDF:
-
- A Loading dose of 2 gms followed by either 1 g thrice daily or 2 gms twice daily.
-
Ceftazidime Dose in Liver Disease:
Dose adjustment is not required in patients with liver disease.
Common Side Effects of Ceftazidime Include:
- Dermatologic:
- Pruritus
- Skin rash
- Endocrine & metabolic:
- Increased lactate dehydrogenase
- Increased gamma-glutamyltransferase
- Gastrointestinal:
- Diarrhea
- Hematologic & oncologic:
- Eosinophilia
- Positive direct Coombs test
- Thrombocythemia
- Hepatic:
- Increased serum ALT
- Increased serum AST
- Increased serum alkaline phosphatase
- Hypersensitivity:
- Hypersensitivity reactions
- Local:
- Inflammation at the injection site
- Injection site phlebitis
- Miscellaneous:
- Fever
Less common side effects of ceftazidime:
- Central nervous system:
- Seizure
- Hematologic & oncologic:
- Agranulocytosis
- Leukopenia
- Lymphocytosis
- Neutropenia
- Thrombocytopenia
- Renal:
- Increased blood urea nitrogen
- Increased serum creatinine
Contraindication to Ceftazidime include:
Hypersensitivity to ceftazidime or other cephalosporins or any component of this formulation
Warnings/Precautions
- Coagulopathy (Elevated iNR):
- Ceftazidime therapy may be used to treat coagulopathy, which is a condition characterized by an increase INR. This is especially true for patients who are nutritionally poor or have hepatic impairment.
- Patients with coagulaopathy may be given Vitamin K.
- Hypersensitivity reactions
- Ceftazidime therapy can cause severe allergic reactions, especially for penicillin- and cephalosporin-allergic patients. If allergic reactions are detected, therapy should be stopped immediately.
- Neurotoxicity:
- Patients with renal impairment and high blood levels of ceftazidime can experience seizures, myoclonia and neuromuscular exitability.
- Patients with impaired renal function should adjust the dose.
- Superinfection
- Ceftriaxone treatment for longer periods (over 2 months) can lead to superinfections, including fungal or bacterial superinfections. C. difficile-associated diarrhea, (CDAD), and pseudomembranous collitis can occur.
- Gastrointestinal Disease:
- Patients suffering from Gastrointestinal Disease, particularly colitis, should be cautious when taking the drug.
- Renal impairment
- To avoid toxic effects in patients with impaired renal function, the dose should be adjusted.
Ceftazidime: Drug Interaction
Note: Drug Interaction Categories:
- Risk Factor C: Monitor When Using Combination
- Risk Factor D: Consider Treatment Modification
- Risk Factor X: Avoid Concomitant Use
Risk Factor C (Monitor therapy). |
|
| Aminoglycosides | Cephalosporins (3rd generation) can increase the nephrotoxic effects of Aminoglycosides. |
| BCG Vaccine (Immunization) | Antibiotics can decrease the therapeutic effects of BCG Vaccine (Immunization). |
| Lactobacillus & Estriol | Antibiotics can reduce the therapeutic effects of Lactobacillus or Estriol. |
| Probenecid | May increase serum Cephalosporins. |
| Vitamin K antagonists (e.g. warfarin). | Cephalosporins can increase the anticoagulant effects of Vitamin K Antagonists. |
Risk Factor D (Regard therapy modification) |
|
| Chloramphenicol (Systemic) | CefTAZidime's therapeutic effects may be diminished. Management: If you require bactericidal activity, consider using another combination of antimicrobials. Monitor for decreased antimicrobial effectiveness or therapeutic failure if these agents are used together. |
| Sodium Picosulfate | Antibiotics can reduce the therapeutic effects of Sodium Picosulfate. Patients who are currently using or have just finished using antibiotics should consider using an alternative product to cleanse the bowels before undergoing a colonoscopy. |
| Typhoid Vaccine | The therapeutic effects of Typhoid vaccine may be diminished by antibiotics. The only affected strain is the live attenuated Ty21a. Patients being treated with systemic antibiotics should avoid vaccination with live attenuated Typhoid vaccine (Ty21a). This vaccine should not be used until at least three days after the cessation or discontinuation of antibacterial agent treatment. |
Risk Factor X (Avoid Combination) |
|
| BCG (Intravesical). | The therapeutic effects of BCG (Intravesical) may be diminished by antibiotics |
| Cholera Vaccine | Cholera Vaccine may be less effective if taken with antibiotics. Treatment: Cholera vaccine should be avoided in patients who have received systemic antibiotics. |
Monitoring Parameters:
Monitor the patient for features of anaphylaxis and clinical improvement/ deterioration.
Monitor renal functions and adjust the dose accordingly.
How to Administer Ceftazidime?
- Intramuscular Ceftazidime should be administered deep into a large mass muscle.
- The intravenous formulation may be administered as an intravenous push over 3 to 5 minutes or by an intravenous intermittent infusion over 15 - 30 minutes.
- Ceftazidime may be also be administered intravitreally as 2 to 2.25 mg/0.1 mL NS in combination with vancomycin in a separate syringe.
- Intraperitoneal administration may be used in conjunction with an Intravenous use for systemic infections if continuous peritoneal dialysis is used. It may be added to the dialysate in each exchange. Inhalation for nebulization may also be used (off-label route) with standard jet nebulizer connected to an air compressor. Administer 1,000 mg diluted in 8 mL NS with mouthpiece or face mask.
Mechanism of action of Ceftazidime:
- Ceftazidime blocks the formation of proteins, peptidoglycans and penicillin-binding proteins.
- This eventually leads to cell lysis through the use of autolytic enzymes.
It works wellabsorbedAfter intramuscular injection, it is widelydistributedAll over the body, including bones, bile and skin, lungs. A mere 10% of the drug's total is available.
Proteins boundIt has been ahalf-life eliminationPatients with severe renal impairment may experience a delay of 1 to 2 hours. The drug can be found in 80 to 90% of the country.excretedUse urine as an unchanged drug.
International Brands of Ceftazidime:
- Baxidyme
- Biotum
- Biozim
- Caltum
- Cef-H
- Cefa 3
- Cefadime
- Cefatum
- Cefaz
- Cefazime
- Cefdim
- Cefidime
- Cefortam
- Cefpiran
- Cefranz
- Ceftadime
- Ceftamil
- Ceftaz
- Ceftazash
- Ceftidin
- Ceftim
- Ceftum
- Celodim
- Cestazid
- Cetazine
- Cetazum
- Cezidin
- Dimcef
- Dimzef
- Elzid
- Extimon
- Fivtum
- Fortaz
- Fortum
- Fortum Pro
- Fortumset
- Forzid
- Ftazidime
- Glazidim
- Izadima
- Kefadim
- Kefazim
- Lacedim
- Lemoxol
- Maxidim
- Megacef
- Mirocef
- Negacef
- Orzid
- Parzidim
- Pharodime
- Romacef
- Septax
- Spectrum
- Starcef
- Tagal
- Tazicef
- Tazidan
- Tazidem
- Thidim
- Tinacef
- Trizidim
- UIzadima
- Xtrazidime
- Zadolina
- Zeptrigen
- Zibac
- Zidimax
- Zidmbiotic
- Zitadim
- Zitum
- Zytaz
Ceftazidime Brands in Pakistan:
|
Ceftazidime [Inj 1 g] Ceftazidime [Inj 1 g] |
|
| AVETAZ | AVENTEK PHARMA |
| BACTAZIME | HAMAZ PHARMACEUTICAL (PVT) LTD. |
| BIOMED | MEDICRAFT PHARMACEUTICALS (PVT) LTD. |
| BIOZID | BIO LABS (PVT) LTD. |
| BLOTAZ | BLOOM PHARMACEUTICALS (PVT) LTD. |
| BREEFORT | PLIVA PAKISTAN (PVT) LIMITED |
| CAYZON | CAYLEX PHARMACEUTICALS (PVT) LTD. |
| CEFAZ | ENGLISH PHARMACEUTICALS INDUSTRIES |
| CEFAZID | MASS PHARMA (PRIVATE) LIMITED |
| CEFCOM | BARRETT HODGSON PAKISTAN (PVT) LTD. |
| CEFODIME | DRUGS INN PAKISTAN |
| CEFOSEL | P.D.H. PHARMACEUTICALS (PVT) LTD. |
| CEFTACIN | LAHORE CHEMICAL & PHARMACEUTICAL WORKS (PVT) LTD |
| CEFTAZ | PHARMEDIC (PVT) LTD. |
| CEFTERA | MEDERA PHARMACEUTICALS (PVT) LTD. |
| CEFWELL | SAYDON PHARMACEUTICAL INDUSTRIES (PVT) LTD. |
| CEFZIMED | MEDICAIDS PAKISTAN (PVT) LTD. |
| CEPLO | CIRIN PHARMACEUTICALS (PVT) LTD. |
| CETADINE | GENOME PHARMACEUTICALS (PVT) LTD |
| CEZAF | S.J. & G. FAZUL ELLAHIE (PVT) LTD. |
| CIZIDIM | SHROOQ PHARMACEUTICALS |
| DAY FORT | HIGH - Q INTERNATIONAL |
| DIMICEF | ELITE PHARMA |
| EFTAX | NEXUS PHARMA (PVT) LTD |
| ELEKT | REDEX PHARMACEUTICAL |
| EPHTUM | REHMAT PHARMA |
| EPOCEF | EPOCH PHARMACEUTICAL |
| EVOZID | PHARMEVO (PVT) LTD. |
| F-NOV | NOVA MED PHARMACEUTICALS |
| FAZIM | POLYFINE CHEMPHARMA (PVT) LTD. |
| FEZADIM | ARDIN PHARMACEUTICALS |
| FITEM | SEARLE PAKISTAN (PVT.) LTD. |
| FORAM | FYNK PHARMACEUTICALS |
| FORDEME | AKSON PHARMACEUTICALS (PVT) LTD. |
| FORSIN | TRIGON PHARMACEUTICALS PAKISTAN (PVT) LTD. |
| FORTAMED | MEDICEENA PHARMA (PVT) LTD. |
| FORTAZIM | BOSCH PHARMACEUTICALS (PVT) LTD. |
| FORTUM | GLAXOSMITHKLINE |
| FORZID | PAKISTAN PHARMACEUTICAL PRODUCTS (PVT) LTD. |
| FOZIDIM | PHARMATEC PAKISTAN (PVT) LTD. |
| FRESZID | MAC & RANS PHARMACEUTICALS (PVT) LTD |
| GENDIME | BIOGEN PHARMA |
| GLOSSON | PULSE PHARMACEUTICALS |
| GRATIN | GRAY`S PHARMACEUTICALS |
| GRATOX | DAEW & CO. PHARMACEUTICALS |
| HARIDONE | SHAWAN PHARMACEUTICALS |
| INJEX | INDUS PHARMA (PVT) LTD. |
| IPRA-DIME | IPRAM INTERNATIONAL |
| JIZDIME | JINNAH PHARMACEUTICALS |
| KAHARA | DANAS PHARMACEUTICALS (PVT) LTD |
| KEFADIM | AGP (PRIVATE) LTD. |
| LIFZIM | LINEAR PHARMA |
| MITAZ | MACTER INTERNATIONAL (PVT) LTD. |
| MORTAM | MACQUINS INTERNATIONAL |
| N-DIME | NENZA PHARMACEUTICALS (PVT) LIMITED |
| NEUDIME | MEDISAVE PHARMACEUTICALS |
| NEUTIM | NEUTRO PHARMA (PVT) LTD. |
| NIVADOR | SAMI PHARMACEUTICALS (PVT) LTD. |
| PAR-FECTION | LIBRA PHARMACEUTICALS (PVT) LTD |
| PARADIME | AGROR PHARMA |
| PATHONIL | GLOBAL PHARMACEUTICALS |
| QISDIM | QINTAR PHARMACUTICALS |
| ROBICEF | ROBINS PHARMACEUTICAL INDUSTRIES |
| SEFTA | GEOFMAN PHARMACEUTICALS |
| SLUSH | W & ALI SONS PHARMACEUTICALS |
| T-ZD | JAWA PHARMACEUTICALS(PVT) LTD. |
| TAZECEF | LOWITT PHARMACEUTICALS (PVT) LTD |
| TAZIDIME | AKHAI PHARMACEUTICALS. |
| TAZOBID | MAKSON PHARMACEUTICALS |
| TEZDA | ALBRO PHARMA |
| TIMS | WISE PHARMACEUTICALS (PVT) LTD |
| TINADEME | ZINTA PHARMACEUTICALS INDUSTRIES |
| TIZID | STANDPHARM PAKISTAN (PVT) LTD. |
| ULTRAZID | BIOREX PHARMACEUTICALS |
| UTAZID | BOSCH PHARMACEUTICALS (PVT) LTD. |
| VALOZID | VALOR PHARMACEUTICALS |
| XIDIM | BROOKES PHARMACEUTICAL LABORATORIES (PAK.) LTD. |
| XTRAZID | SURGE LABORATORIES (PVT) LTD. |
| Z.D | LEADS PHARMA (PVT) LTD |
| ZATRON | TABROS PHARMA |
| ZAYDIME | ZAYNOON PHARMACEUTICALS |
| ZIPENTA | ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. |
| ZITUM | WILSHIRE LABORATORIES (PVT) LTD. |
| ZORTUM | Z-JANS PHARMACEUTICAL (PVT) LTD. |
|
Ceftazidime [Inj 250 mg] |
|
| ASTEDIME | ASTELLAS PHARMACEUTICALS |
| BACTAZIME | HAMAZ PHARMACEUTICAL (PVT) LTD. |
| BIOMED | MEDICRAFT PHARMACEUTICALS (PVT) LTD. |
| BIOZID | BIO LABS (PVT) LTD. |
| BLOTAZ | BLOOM PHARMACEUTICALS (PVT) LTD. |
| BREEFORT | PLIVA PAKISTAN (PVT) LIMITED |
| CAYZON | CAYLEX PHARMACEUTICALS (PVT) LTD. |
| CEFAROWN | CROWN PHARMACEUTICALS |
| CEFAZ | ENGLISH PHARMACEUTICALS INDUSTRIES |
| CEFAZID | MASS PHARMA (PRIVATE) LIMITED |
| CEFCOM | BARRETT HODGSON PAKISTAN (PVT) LTD. |
| CEFODIME | DRUGS INN PAKISTAN |
| CEFOSEL | P.D.H. PHARMACEUTICALS (PVT) LTD. |
| CEFTACIN | LAHORE CHEMICAL & PHARMACEUTICAL WORKS (PVT) LTD |
| CEFTAZ | PHARMEDIC (PVT) LTD. |
| CEFTERA | MEDERA PHARMACEUTICALS (PVT) LTD. |
| CEFWELL | SAYDON PHARMACEUTICAL INDUSTRIES (PVT) LTD. |
| CEFZIMED | MEDICAIDS PAKISTAN (PVT) LTD. |
| CEPLO | CIRIN PHARMACEUTICALS (PVT) LTD. |
| CETADINE | GENOME PHARMACEUTICALS (PVT) LTD |
| CEZAF | S.J. & G. FAZUL ELLAHIE (PVT) LTD. |
| CIZIDIM | SHROOQ PHARMACEUTICALS |
| DAY FORT | HIGH - Q INTERNATIONAL |
| EFTAX | NEXUS PHARMA (PVT) LTD |
| ELEKT | REDEX PHARMACEUTICAL |
| EPHTUM | REHMAT PHARMA |
| EPOCEF | EPOCH PHARMACEUTICAL |
| EVOZID | PHARMEVO (PVT) LTD. |
| F-NOV | NOVA MED PHARMACEUTICALS |
| FAZIM | POLYFINE CHEMPHARMA (PVT) LTD. |
| FEZADIM | ARDIN PHARMACEUTICALS |
| FITEM | SEARLE PAKISTAN (PVT.) LTD. |
| FORAM | FYNK PHARMACEUTICALS |
| FORDEME | AKSON PHARMACEUTICALS (PVT) LTD. |
| FORSIN | TRIGON PHARMACEUTICALS PAKISTAN (PVT) LTD. |
| FORTAMED | MEDICEENA PHARMA (PVT) LTD. |
| FORTAZIM | BOSCH PHARMACEUTICALS (PVT) LTD. |
| FORTUM | GLAXOSMITHKLINE |
| FOZIDIM | PHARMATEC PAKISTAN (PVT) LTD. |
| FRESZID | MAC & RANS PHARMACEUTICALS (PVT) LTD |
| GENDIME | BIOGEN PHARMA |
| GLOSSON | PULSE PHARMACEUTICALS |
| GRATIN | GRAY`S PHARMACEUTICALS |
| GRATOX | DAEW & CO. PHARMACEUTICALS |
| HARIDONE | SHAWAN PHARMACEUTICALS |
| INJEX | INDUS PHARMA (PVT) LTD. |
| IPRA-DIME | IPRAM INTERNATIONAL |
| JIZDIME | JINNAH PHARMACEUTICALS |
| KAHARA | DANAS PHARMACEUTICALS (PVT) LTD |
| KEFADIM | AGP (PRIVATE) LTD. |
| LIFZIM | LINEAR PHARMA |
| MITAZ | MACTER INTERNATIONAL (PVT) LTD. |
| MORTAM | MACQUINS INTERNATIONAL |
| N-DIME | NENZA PHARMACEUTICALS (PVT) LIMITED |
| NEUTIM | NEUTRO PHARMA (PVT) LTD. |
| NIVADOR | SAMI PHARMACEUTICALS (PVT) LTD. |
| PAR-FECTION | LIBRA PHARMACEUTICALS (PVT) LTD |
| PARADIME | AGROR PHARMA |
| PATHONIL | GLOBAL PHARMACEUTICALS |
| QISDIM | QINTAR PHARMACUTICALS |
| ROBICEF | ROBINS PHARMACEUTICAL INDUSTRIES |
| SATSIN | BRYON PHARMACEUTICALS (PVT) LTD. |
| SEFTA | GEOFMAN PHARMACEUTICALS |
| SLUSH | W & ALI SONS PHARMACEUTICALS |
| T-ZD | JAWA PHARMACEUTICALS(PVT) LTD. |
| TAZECEF | LOWITT PHARMACEUTICALS (PVT) LTD |
| TAZIDIME | AKHAI PHARMACEUTICALS. |
| TAZOBID | MAKSON PHARMACEUTICALS |
| TIMS | WISE PHARMACEUTICALS (PVT) LTD |
| TIZID | STANDPHARM PAKISTAN (PVT) LTD. |
| ULTRAZID | BIOREX PHARMACEUTICALS |
| UTAZID | BOSCH PHARMACEUTICALS (PVT) LTD. |
| VALOZID | VALOR PHARMACEUTICALS |
| XTRADIM | ALKEMY PHARMACEUTICAL LABORATORIES (PRIVATE) LTD. |
| XTRAZID | SURGE LABORATORIES (PVT) LTD. |
| Z.D | LEADS PHARMA (PVT) LTD |
| ZATRON | TABROS PHARMA |
| ZAYDIME | ZAYNOON PHARMACEUTICALS |
| ZIPENTA | ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. |
| ZITUM | WILSHIRE LABORATORIES (PVT) LTD. |
| ZORTUM | Z-JANS PHARMACEUTICAL (PVT) LTD. |
|
Ceftazidime [Inj 500 mg] |
|
| BACTAZIME | HAMAZ PHARMACEUTICAL (PVT) LTD. |
| BIOMED | MEDICRAFT PHARMACEUTICALS (PVT) LTD. |
| BIOZID | BIO LABS (PVT) LTD. |
| BLOTAZ | BLOOM PHARMACEUTICALS (PVT) LTD. |
| BREEFORT | PLIVA PAKISTAN (PVT) LIMITED |
| CAYZON | CAYLEX PHARMACEUTICALS (PVT) LTD. |
| CEFAROWN | CROWN PHARMACEUTICALS |
| CEFAZ | ENGLISH PHARMACEUTICALS INDUSTRIES |
| CEFCOM | BARRETT HODGSON PAKISTAN (PVT) LTD. |
| CEFOSEL | P.D.H. PHARMACEUTICALS (PVT) LTD. |
| CEFTACIN | LAHORE CHEMICAL & PHARMACEUTICAL WORKS (PVT) LTD |
| CEFTAZ | PHARMEDIC (PVT) LTD. |
| CEFWELL | SAYDON PHARMACEUTICAL INDUSTRIES (PVT) LTD. |
| CEPLO | CIRIN PHARMACEUTICALS (PVT) LTD. |
| CETADINE | GENOME PHARMACEUTICALS (PVT) LTD |
| CEZAF | S.J. & G. FAZUL ELLAHIE (PVT) LTD. |
| CIZIDIM | SHROOQ PHARMACEUTICALS |
| DAY FORT | HIGH - Q INTERNATIONAL |
| DIMICEF | ELITE PHARMA |
| EFTAX | NEXUS PHARMA (PVT) LTD |
| EPHTUM | REHMAT PHARMA |
| EPOCEF | EPOCH PHARMACEUTICAL |
| EVOZID | PHARMEVO (PVT) LTD. |
| F-NOV | NOVA MED PHARMACEUTICALS |
| FAZIM | POLYFINE CHEMPHARMA (PVT) LTD. |
| FEZADIM | ARDIN PHARMACEUTICALS |
| FITEM | SEARLE PAKISTAN (PVT.) LTD. |
| FORAM | FYNK PHARMACEUTICALS |
| FORDEME | AKSON PHARMACEUTICALS (PVT) LTD. |
| FORSIN | TRIGON PHARMACEUTICALS PAKISTAN (PVT) LTD. |
| FORTAMED | MEDICEENA PHARMA (PVT) LTD. |
| FORTAZIM | BOSCH PHARMACEUTICALS (PVT) LTD. |
| FORTUM | GLAXOSMITHKLINE |
| FORZID | PAKISTAN PHARMACEUTICAL PRODUCTS (PVT) LTD. |
| FOZIDIM | PHARMATEC PAKISTAN (PVT) LTD. |
| GENDIME | BIOGEN PHARMA |
| GLOSSON | PULSE PHARMACEUTICALS |
| HARIDONE | SHAWAN PHARMACEUTICALS |
| INJEX | INDUS PHARMA (PVT) LTD. |
| IPRA-DIME | IPRAM INTERNATIONAL |
| JIZDIME | JINNAH PHARMACEUTICALS |
| KAHARA | DANAS PHARMACEUTICALS (PVT) LTD |
| KEFADIM | AGP (PRIVATE) LTD. |
| LIFZIM | LINEAR PHARMA |
| MITAZ | MACTER INTERNATIONAL (PVT) LTD. |
| MORTAM | MACQUINS INTERNATIONAL |
| N-DIME | NENZA PHARMACEUTICALS (PVT) LIMITED |
| NEUDIME | MEDISAVE PHARMACEUTICALS |
| NEUTIM | NEUTRO PHARMA (PVT) LTD. |
| NIVADOR | SAMI PHARMACEUTICALS (PVT) LTD. |
| PAR-FECTION | LIBRA PHARMACEUTICALS (PVT) LTD |
| PATHONIL | GLOBAL PHARMACEUTICALS |
| ROBICEF | ROBINS PHARMACEUTICAL INDUSTRIES |
| SATSIN | BRYON PHARMACEUTICALS (PVT) LTD. |
| SEFTA | GEOFMAN PHARMACEUTICALS |
| TAZECEF | LOWITT PHARMACEUTICALS (PVT) LTD |
| TAZIDIME | AKHAI PHARMACEUTICALS. |
| TAZOBID | MAKSON PHARMACEUTICALS |
| TEZDA | ALBRO PHARMA |
| TINADEME | ZINTA PHARMACEUTICALS INDUSTRIES |
| TIZID | STANDPHARM PAKISTAN (PVT) LTD. |
| ULTRAZID | BIOREX PHARMACEUTICALS |
| UTAZID | BOSCH PHARMACEUTICALS (PVT) LTD. |
| VALOZID | VALOR PHARMACEUTICALS |
| XIDIM | BROOKES PHARMACEUTICAL LABORATORIES (PAK.) LTD. |
| XTRADIM | ALKEMY PHARMACEUTICAL LABORATORIES (PRIVATE) LTD. |
| XTRAZID | SURGE LABORATORIES (PVT) LTD. |
| Z.D | LEADS PHARMA (PVT) LTD |
| ZATRON | TABROS PHARMA |
| ZAYDIME | ZAYNOON PHARMACEUTICALS |
| ZIPENTA | ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. |
| ZITUM | WILSHIRE LABORATORIES (PVT) LTD. |
| ZORTUM | Z-JANS PHARMACEUTICAL (PVT) LTD. |
.png)
